These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31147892)

  • 1. CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator.
    Yawata T; Higashi Y; Kawanishi Y; Nakajo T; Fukui N; Fukuda H; Ueba T
    J Neurooncol; 2019 Aug; 144(1):21-32. PubMed ID: 31147892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
    Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
    Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
    Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
    Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
    PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.
    Dzaye O; Hu F; Derkow K; Haage V; Euskirchen P; Harms C; Lehnardt S; Synowitz M; Wolf SA; Kettenmann H
    J Neuropathol Exp Neurol; 2016 May; 75(5):429-40. PubMed ID: 27030742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells.
    Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H
    Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
    Fukui N; Yawata T; Nakajo T; Kawanishi Y; Higashi Y; Yamashita T; Aratake T; Honke K; Ueba T
    J Neurosurg; 2021 Jun; 134(6):1772-1782. PubMed ID: 32707539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling.
    Liang Y; Voshart D; Paridaen JTML; Oosterhof N; Liang D; Thiruvalluvan A; Zuhorn IS; den Dunnen WFA; Zhang G; Lin H; Barazzuol L; Kruyt FAE
    Cell Mol Life Sci; 2022 Jul; 79(8):398. PubMed ID: 35790583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
    Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
    Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
    Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced invasion in vitro and the distribution patterns in vivo of CD133+ glioma stem cells.
    Yu SP; Yang XJ; Zhang B; Ming HL; Chen C; Ren BC; Liu ZF; Liu B
    Chin Med J (Engl); 2011 Sep; 124(17):2599-604. PubMed ID: 22040410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PER2 inhibits proliferation and stemness of glioma stem cells via the Wnt/β‑catenin signaling pathway.
    Ma D; Hou L; Xia H; Li H; Fan H; Jia X; Niu Z
    Oncol Rep; 2020 Aug; 44(2):533-542. PubMed ID: 32468039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.
    Li Y; Li L; Wu Z; Wang L; Wu Y; Li D; Ma U; Shao J; Yu H; Wang D
    Oncol Rep; 2017 Jul; 38(1):325-335. PubMed ID: 28560406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
    Li C; Yan Z; Cao X; Zhang X; Yang L
    J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.